Search Results - "PETTIBONE, Douglas J"
-
1
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Published in Pharmacological reviews (01-03-2005)“…Kinins are proinflammatory peptides that mediate numerous vascular and pain responses to tissue injury. Two pharmacologically distinct kinin receptor subtypes…”
Get full text
Journal Article -
2
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models
Published in The Journal of pharmacology and experimental therapeutics (01-04-2005)“…We found that 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) is a potent and selective positive allosteric modulator of the metabotropic glutamate…”
Get more information
Journal Article -
3
N-Desmethylclozapine, an Allosteric Agonist at Muscarinic 1 Receptor, Potentiates N-Methyl-D-Aspartate Receptor Activity
Published in Proceedings of the National Academy of Sciences - PNAS (11-11-2003)“…The molecular and neuronal substrates conferring on clozapine its unique and superior efficacy in the treatment of schizophrenia remain elusive. The…”
Get full text
Journal Article -
4
A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5
Published in Molecular pharmacology (01-09-2003)“…We have identified a family of highly selective allosteric modulators of the group I metabotropic glutamate receptor subtype 5 (mGluR5). This family of closely…”
Get more information
Journal Article -
5
A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain
Published in The Journal of pharmacology and experimental therapeutics (01-05-2004)“…We found that N-[4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide (CPPHA), is a potent and selective positive allosteric…”
Get more information
Journal Article -
6
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin
Published in The Journal of pharmacology and experimental therapeutics (01-01-2002)“…Mice deficient in the neurotensin (NT)-1 receptor (NTR1) were developed to characterize the NT receptor subtypes that mediate various in vivo responses to NT…”
Get more information
Journal Article -
7
Design, Synthesis, and In Vivo Efficacy of Glycine Transporter-1 (GlyT1) Inhibitors Derived from a Series of [4-Phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl Benzamides
Published in ChemMedChem (11-08-2006)“…An iterative analogue library synthesis approach rapidly delivered (S)‐13 h, a potent, reversible, and selective GlyT1 inhibitor. (S)‐13 h selectively…”
Get full text
Journal Article -
8
Discovery of a Potent, Non-peptide Bradykinin B1 Receptor Antagonist
Published in Journal of the American Chemical Society (25-06-2003)“…Bradykinin (BK) plays an important role in the pathophysiological processes accompanying pain and inflammation. Selective bradykinin B1 receptor antagonists…”
Get full text
Journal Article -
9
Development of a scintillation proximity assay for analysis of Na +/Cl −-dependent neurotransmitter transporter activity
Published in Analytical biochemistry (01-10-2003)“…Human placental choriocarcinoma (JAR) cells endogenously expressing glycine transporter type 1a (GlyT1a) have been cultured in 96-well scintillating…”
Get full text
Journal Article -
10
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
Published in The Journal of pharmacology and experimental therapeutics (01-08-2004)“…Antagonists of the B1 bradykinin receptor (B1R) offer the promise of novel therapeutic agents for the treatment of inflammatory and neuropathic pain. However,…”
Get more information
Journal Article -
11
Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines
Published in Journal of medicinal chemistry (04-06-1998)“…The previously reported oxytocin antagonist L-371,257 (2) has been modified at its acetylpiperidine terminus to incorporate various pyridine N-oxide groups…”
Get full text
Journal Article -
12
Bradykinin B1 receptor antagonists : An α-hydroxy amide with an improved metabolism profile
Published in Bioorganic & medicinal chemistry letters (15-09-2008)“…A series of carbo- and heterocyclic alpha-hydroxy amide-derived bradykinin B1 antagonists was prepared and evaluated. A 4,4-difluorocyclohexyl alpha-hydroxy…”
Get full text
Journal Article -
13
Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists
Published in Journal of medicinal chemistry (25-01-2007)“…A series of biphenylaminocyclopropane carboxamide based bradykinin B1 receptor antagonists has been developed that possesses good pharmacokinetic properties…”
Get full text
Journal Article -
14
Indazole derivatives as novel bradykinin B1 receptor antagonists
Published in Bioorganic & medicinal chemistry letters (01-12-2010)“…A new class of indazole-derived bradykinin B(1) antagonists and their structure-activity relationships (SAR) is reported. A number of compounds were found to…”
Get full text
Journal Article -
15
Pharmacology and expression analysis of glycine transporter GlyT1 with [ 3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine
Published in Neuropharmacology (01-10-2003)“…In the central nervous system, re-uptake of the neurotransmitter glycine is mediated by two different glycine transporters, GlyT1 and GlyT2. GlyT2 is found in…”
Get full text
Journal Article -
16
Orally active, nonpeptide oxytocin antagonists
Published in Journal of medicinal chemistry (01-10-1992)“…The first nonpeptide antagonists of the neurohypophyseal hormone, oxytocin (OT) are described. Derivatives of the spiroindenepiperidine ring system, these…”
Get full text
Journal Article -
17
Effects of typical and atypical antipsychotics on human glycine transporters
Published in Schizophrenia research (01-11-2004)“…Augmentation strategy in the treatment of schizophrenia with the NMDA receptor co-agonist glycine has demonstrated significant improvement in patient symptoms…”
Get full text
Journal Article -
18
2-Aminobenzophenones as a Novel Class of Bradykinin B1 Receptor Antagonists
Published in Journal of medicinal chemistry (10-07-2008)“…Selective bradykinin (BK) B1 receptor antagonists could be novel therapeutic agents for the treatment of pain and inflammation. Elucidation of the structure…”
Get full text
Journal Article -
19
Cyclopropylamino Acid Amide as a Pharmacophoric Replacement for 2,3-Diaminopyridine. Application to the Design of Novel Bradykinin B1 Receptor Antagonists
Published in Journal of medicinal chemistry (23-02-2006)“…Antagonism of the bradykinin B1 receptor represents a potential treatment for chronic pain and inflammation. Novel antagonists were designed that display…”
Get full text
Journal Article -
20
Bradykinin B1 antagonists : Biphenyl SAR studies in the cyclopropanecarboxamide series
Published in Bioorganic & medicinal chemistry letters (01-07-2007)“…SAR study of the biphenyl region of cyclopropanecarboxamide derived bradykinin B(1) antagonists was examined. Incorporation of a pyridine in place of the…”
Get full text
Journal Article